Germline BRCA-Mutated HER2-Negative Advanced Breast Cancer: Overcoming Challenges in Genetic Testing and Clinical Considerations When Using Talazoparib.
Saved in:
| Title: | Germline BRCA-Mutated HER2-Negative Advanced Breast Cancer: Overcoming Challenges in Genetic Testing and Clinical Considerations When Using Talazoparib. |
|---|---|
| Authors: | Brugioni E; Mission Blood + Cancer, Des Moines, IA. Electronic address: ebrugioni@missioncancer.com., Cathcart-Rake E; Mayo Clinic, Rochester, MN., Metsker J; Saint Luke's Hospital, Kansas City, MO., Gustafson E; Saint Luke's Hospital, University of Missouri, Kansas City, MO., Douglass L; Saint Luke's Hospital, University of Missouri, Kansas City, MO., Pluard TJ; Saint Luke's Cancer Institute, University of Missouri, Kansas City, MO. |
| Source: | Clinical breast cancer [Clin Breast Cancer] 2023 Jul; Vol. 23 (5), pp. 469-477. Date of Electronic Publication: 2023 Apr 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1938-0666 |
|---|---|
| DOI: | 10.1016/j.clbc.2023.04.006 |
